NUWE Nuwellis, Inc.: שולי רווח תפעולי

Nuwellis, Inc. (NUWE) operates within a neutral US environment where the humanitarian status of medical systems offsets external risks. The operating margin time series reflects the current market consensus, with the value of -135.80 serving as the current metric. Revenues are based on the implementation of Aquadex in cardiology and the sale of consumables. High scalability is driven by high-margin sterile components that lock clinics into the manufacturer's ecosystem.
Nuwellis, Inc. - פילוחים אנליטיים ומדדי מפתח (NUWE)

For Nuwellis, Inc. (NUWE), which develops Aquadex systems for gentle blood ultrafiltration, the operating margin determines the share of profit from the sale of medical technologies in total revenue before taxes and interest obligations. By analyzing the business's operational efficiency, an investor assesses the company's ability to cover current costs, where growth in this metric confirms the sustainability of the model and the margin of safety for debt service.